Investigating Transporter‐Mediated Drug‐Drug Interactions Using a Physiologically Based Pharmacokinetic Model of Rosuvastatin

Rosuvastatin is a frequently used probe in transporter‐mediated drug‐drug interaction (DDI) studies. This report describes the development of a physiologically based pharmacokinetic (PBPK) model of rosuvastatin for prediction of pharmacokinetic (PK) DDIs. The rosuvastatin model predicted the observe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Q, Zheng, M, Leil, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397561/
https://www.ncbi.nlm.nih.gov/pubmed/28296193
http://dx.doi.org/10.1002/psp4.12168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397561/
https://www.ncbi.nlm.nih.gov/pubmed/28296193
http://dx.doi.org/10.1002/psp4.12168

Ejemplares similares